Ben-Dor Itsik, Gaglia Michael A, Barbash Israel M, Maluenda Gabriel, Hauville Camille, Gonzalez Manuel A, Sardi Gabriel, Laynez-Carnicero Ana, Torguson Rebecca, Okubagzi Petros, Xue Zhenyi, Goldstein Steven A, Suddath William O, Kent Kenneth M, Lindsay Joseph, Satler Lowell F, Pichard Augusto D, Waksman Ron
Interventional Cardiology, Washington Hospital Center, Washington, DC 20010, USA.
Cardiovasc Revasc Med. 2011 Nov-Dec;12(6):345-9. doi: 10.1016/j.carrev.2011.04.005. Epub 2011 Jul 7.
The primary inclusion criteria from both the Society of Thoracic Surgeons (STS) score and the logistic EuroSCORE are currently used to identify high-risk and inoperable patients eligible for transcatheter aortic valve implantation (TAVI). We aimed to examine the correlation between STS and logistic EuroSCOREs and their performance characteristics in patients referred for TAVI.
The study cohort consisted of 718 high-risk patients with severe aortic stenosis who were considered for participation in a TAVI clinical trial. The performance of the STS and logistic EuroSCOREs was evaluated in three groups: (a) medical management or balloon aortic valvuloplasty (BAV), 474 (66%); (b) 133 patients (18.5%) with surgical aortic valve replacement (AVR); (c) 111 (15.4%) with TAVI. The mean age was 81.8 ± 8.1 years, and 394 (54.8%) were female.
The mean STS score was 11.5 ± 6.1, and the mean logistic EuroSCORE was 39.7 ± 23.0. Pearson correlation coefficient showed moderate correlation between the STS and logistic EuroSCOREs (r = 0.61, P < .001). At a median follow-up of 190 days (range, 67-476), 282 patients (39.2%) died. The STS and logistic EuroSCOREs were both higher in patients who died as compared to those in survivors (13.1 ± 6.2 vs.10.0 ± 5.8 and 43.4 ± 23.1 vs. 37.5 ± 22, respectively; P < .001). The observed and predicted 30-day mortality rates in the medical/BAV group were 10.1% observed, 12.3% by STS and 43.1% by logistic EuroSCORE. In the surgical AVR group, the rates were 12.8% observed, 8.4% by STS and 25.6% by logistic EuroSCORE. In the TAVI group, the rates were 11.7% observed, 11.8% by STS and 41.2% by logistic EuroSCORE. The odds ratio (OR) for 30-day mortality in the medical/BAV group was 1.05 (P = .01) with STS and 1.003 (P = .7) with logistic EuroSCORE. In the surgical AVR group, the OR was 1.09 (P = .07) with STS and 1.007 (P = .6) with logistic EuroSCORE. In the TAVI group, the OR was 1.14 (P = .03) with STS and 1.03 (P = .04) with logistic EuroSCORE.
In high-risk patients with severe aortic stenosis, STS score is superior to the logistic EuroSCORE in predicting mortality. Clinical judgment should play a major role in the selection of patients with severe aortic stenosis for the different therapeutic options.
胸外科医师协会(STS)评分和逻辑欧洲心脏手术风险评估系统(logistic EuroSCORE)的主要纳入标准目前用于识别适合经导管主动脉瓣植入术(TAVI)的高危和不可手术患者。我们旨在研究STS评分与logistic EuroSCORE之间的相关性及其在接受TAVI评估患者中的性能特征。
研究队列包括718例患有严重主动脉瓣狭窄的高危患者,这些患者被考虑参与一项TAVI临床试验。在三组中评估了STS评分和logistic EuroSCORE的性能:(a)药物治疗或球囊主动脉瓣成形术(BAV),474例(66%);(b)133例(18.5%)接受外科主动脉瓣置换术(AVR)的患者;(c)111例(15.4%)接受TAVI的患者。平均年龄为81.8±8.1岁,394例(54.8%)为女性。
平均STS评分为11.5±6.1,平均logistic EuroSCORE为39.7±23.0。Pearson相关系数显示STS评分与logistic EuroSCORE之间存在中度相关性(r = 0.61,P <.001)。在中位随访190天(范围67 - 476天)时,282例患者(39.2%)死亡。与幸存者相比,死亡患者的STS评分和logistic EuroSCORE均更高(分别为13.1±6.2对10.0±5.8以及43.4±23.1对37.5±22;P <.001)。在药物治疗/BAV组中,观察到的30天死亡率为10.1%,STS预测的为12.3%,logistic EuroSCORE预测的为43.1%。在外科AVR组中,观察到的死亡率为12.8%,STS预测的为8.4%,logistic EuroSCORE预测的为25.6%。在TAVI组中,观察到的死亡率为11.7%,STS预测的为11.8%,logistic EuroSCORE预测的为41.2%。药物治疗/BAV组30天死亡率的比值比(OR),STS为1.05(P =.01),logistic EuroSCORE为1.003(P =.7)。在外科AVR组中,STS的OR为1.09(P =.07),logistic EuroSCORE的OR为1.007(P =.6)。在TAVI组中,STS的OR为1.14(P =.03),logistic EuroSCORE的OR为1.03(P =.04)。
在患有严重主动脉瓣狭窄的高危患者中,STS评分在预测死亡率方面优于logistic EuroSCORE。临床判断在为严重主动脉瓣狭窄患者选择不同治疗方案时应起主要作用。